Play all audios:
Biological and lifestyle differences cannot fully explain infection spike among trial participants. Access through your institution Buy or subscribe This is a preview of subscription
content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 51 print issues and online access $199.00 per year only $3.90 per issue
Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL
ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support REFERENCES * Hammer, S. M. et al. _N. Engl. J. Med._
http://dx.doi.org/10.1056/NEJMoa1310566 (2013). * Rerks-Ngarm, S. et al. _N. Engl. J. Med._ 361, 2209-2220 (2009). Article CAS Google Scholar Download references Authors * Sara Reardon
View author publications You can also search for this author inPubMed Google Scholar RELATED LINKS RELATED LINKS RELATED LINKS IN NATURE RESEARCH Mystery of HIV vaccine failure deepens
2009-Jul-20 HIV vaccine failure explained? 2008-Nov-05 HIV vaccine may raise risk 2007-Nov-14 HIV: The Next Shot RELATED EXTERNAL LINKS AIDS Vaccine Conference 2013 HIV Vaccine Trials
Network RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Reardon, S. HIV vaccine raised infection risk. _Nature_ (2013).
https://doi.org/10.1038/nature.2013.13971 Download citation * Published: 17 October 2013 * DOI: https://doi.org/10.1038/nature.2013.13971 SHARE THIS ARTICLE Anyone you share the following
link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature
SharedIt content-sharing initiative